With a market cap of $13.3 billion, The Clorox Company (CLX) is a consumer products company that focuses on delivering innovative solutions across household, health, wellness and personal care categories. Its portfolio includes well-known brands such as Clorox, Brita, Burt’s Bees, Glad, Fresh Step, Hidden Valley, Kingsford, Liquid-Plumr, Pine-Sol and Purell.
Shares of the Oakland, California-based company have outperformed the broader market over the past 52 weeks. CLX stock has risen 9.3% over this time frame, while the broader S&P 500 Index ($SPX) has gained 8.3%. However, shares of the company are up 6.3% on a YTD basis, lagging behind SPX’s 10.1% increase.
Looking closer, the consumer products maker stock has underperformed the State Street Consumer Staples Select Sector SPDR ETF’s (XLP) 19.9% return over the past 52 weeks.
Clorox shares rose 2.2% on Nov. 2 after the company reported fiscal Q1 2027 adjusted EPS of $1.55, up 82% year-over-year and well above the consensus estimate. Sales jumped 33% to $1.91 billion, driven by the GOJO acquisition, while organic sales increased 18%, with health and wellness segment sales surging 62%. Investor sentiment was further supported by the company's full-year sales growth guidance of 13% - 14%, although management cautioned that higher inflation, commodity prices, and manufacturing and logistics costs were creating a more challenging cost environment.
For the fiscal year ending in June 2027, analysts expect Clorox’s adjusted EPS to grow 3.8% year-over-year to $5.74. The company’s earnings surprise history is mixed. It beat the consensus estimates in three of the last four quarters while missing on another occasion.
Among the 18 analysts covering the stock, the consensus rating is a “Hold.” That’s based on 14 “Hold” ratings and four “Strong Sells.”
This configuration is slightly more bullish than three months ago, with 13 “Strong Buy” ratings on the stock.
On Oct. 19, JPMorgan analyst Andrea Teixeira cut its price target on Clorox to $83, maintaining an “Underweight” rating.
As of writing, the stock is trading above both the mean price target of $94.31 and the Street-high price target of $110.